Skip to content

A study on management of rheumatoid arthritis using siddha medicine maha analuruva chooranam

Phase II non randomized open clinical evaluation of siddha medicine maha analuruva chooranam for the management of uthiravatha suronitham (Rheumatoid arthritis) - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059780
Enrollment
40
Registered
2023-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M060- Rheumatoid arthritis without rheumatoid factor

Interventions

Intervention1: MAHA ANALURUVA CHOORANAM: This is a siddha herbal medicine for the management of Rheumatoid arthritis.It will be given as oral route in the dose of 1.5 gm (BD) with honey for the durati

Sponsors

Dr Dharani P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age limit - 18 to 50 years All genders Morning stiffness more than 1 hour Arthritis of more than 3 joints Symmetrical arthritis Patients positive for anti-CCP

Exclusion criteria

Exclusion criteria: Rheumatic fever Psoriatic arthropathy Gouty athritis Any other serious systemic illness Pregnant women and lactating mothers Type 2 diabetes mellitus The above criteria will be excluded clinically or based on the available medical reports.

Design outcomes

Primary

MeasureTime frame
The outcome will be mainly assessed by reduction in clinical symptoms such as severity of pain,reduction of swelling and morning stiffness.Timepoint: 3 weeks

Secondary

MeasureTime frame
Assesing the improvement of patient from severe to moderate,moderate to mild through universal pain assessment scale (VISUAL ANALOGUE SCALE) and reduction in Anti-CCP levels which helps to ensure the wellness of patient.Timepoint: 7 Weeks

Countries

India

Contacts

Public ContactDr Dharani P

Government siddha medical college, Arumbakkam, Chennai 106.

mmsankar2000@gmail.com9445716802

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026